FI941876A7 - Uusia 2,6-disubstituoituja puriinijohdannaisia - Google Patents

Uusia 2,6-disubstituoituja puriinijohdannaisia Download PDF

Info

Publication number
FI941876A7
FI941876A7 FI941876A FI941876A FI941876A7 FI 941876 A7 FI941876 A7 FI 941876A7 FI 941876 A FI941876 A FI 941876A FI 941876 A FI941876 A FI 941876A FI 941876 A7 FI941876 A7 FI 941876A7
Authority
FI
Finland
Prior art keywords
new
purine derivatives
disubstituted purine
disubstituted
derivatives
Prior art date
Application number
FI941876A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI941876A0 (fi
FI941876L (fi
Inventor
Lars Jacob Stray Knutsen
Jesper Lau
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI941876A0 publication Critical patent/FI941876A0/fi
Publication of FI941876L publication Critical patent/FI941876L/fi
Publication of FI941876A7 publication Critical patent/FI941876A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI941876A 1991-10-24 1992-10-21 Uusia 2,6-disubstituoituja puriinijohdannaisia FI941876A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK9100324 1991-10-24
PCT/DK1992/000307 WO1993008206A1 (en) 1991-10-24 1992-10-21 Novel 2,6-disubstituted purine derivatives

Publications (3)

Publication Number Publication Date
FI941876A0 FI941876A0 (fi) 1994-04-22
FI941876L FI941876L (fi) 1994-06-22
FI941876A7 true FI941876A7 (fi) 1994-06-22

Family

ID=8153695

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941876A FI941876A7 (fi) 1991-10-24 1992-10-21 Uusia 2,6-disubstituoituja puriinijohdannaisia

Country Status (11)

Country Link
US (2) US5432164A (enExample)
EP (1) EP0609375A1 (enExample)
JP (1) JPH07500586A (enExample)
AU (1) AU657374B2 (enExample)
CA (1) CA2121844A1 (enExample)
FI (1) FI941876A7 (enExample)
IL (1) IL103513A (enExample)
NO (1) NO300461B1 (enExample)
NZ (1) NZ244875A (enExample)
WO (1) WO1993008206A1 (enExample)
ZA (1) ZA928222B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432164A (en) * 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
EP0704215A3 (en) * 1994-06-02 1998-04-01 Takeda Chemical Industries, Ltd. Inhibitor of vascular permeability enhancer
AU2022497A (en) * 1996-03-13 1997-10-01 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
AU2022597A (en) * 1996-03-13 1997-10-01 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
RU2172320C2 (ru) * 1996-08-27 2001-08-20 Си Ви Терапьютикс, Инк. Производные аденозина, фармацевтическая композиция и способ коррекции электрических нарушений в сердце млекопитающего
WO1998016539A1 (en) * 1996-10-14 1998-04-23 Novo Nordisk A/S Novel therapeutically active adenosine derivatives
US6110902A (en) * 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
US6175004B1 (en) * 1998-09-01 2001-01-16 Isis Pharmaceuticals, Inc. Process for the synthesis of oligonucleotides incorporating 2-aminoadenosine
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists
US6294522B1 (en) * 1999-12-03 2001-09-25 Cv Therapeutics, Inc. N6 heterocyclic 8-modified adenosine derivatives
US7342003B2 (en) * 2001-10-25 2008-03-11 King Pharmaceuticals Research And Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
KR20050097971A (ko) * 2003-02-03 2005-10-10 씨브이 쎄러퓨틱스, 인코포레이티드 Ａ₁아데노신 수용체의 부분 및 전 작용제
WO2005033121A2 (en) * 2003-10-03 2005-04-14 King Pharmaceuticals Research & Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
US20100048501A1 (en) 2006-03-21 2010-02-25 Heinrich-Heine-Universitat Dusseldorf Phosphorylated A2A Receptor Agonists
MX361102B (es) 2013-12-19 2018-11-27 Procter & Gamble Modelado de fibras de queratina con el uso de un agente activo que comprende al menos dos grupos funcionales seleccionados de: -c(oh)- y -c(=o)oh.
CN107106438A (zh) 2014-12-19 2017-08-29 宝洁公司 成形角蛋白纤维的方法
EP3297731A1 (en) 2014-12-19 2018-03-28 The Procter and Gamble Company Shaping keratin fibres using arabinose and ethylene carbonate
JP2026500305A (ja) 2022-12-16 2026-01-06 アストラゼネカ・アクチエボラーグ ２，６，９三置換プリン

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3796700A (en) * 1970-06-30 1974-03-12 Takedo Chem Ind Ltd Adenosine derivatives and the production thereof
JPH0696534B2 (ja) * 1986-04-25 1994-11-30 ヘキストジヤパン株式会社 抗痴呆剤
US5017578A (en) * 1989-06-09 1991-05-21 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents
EP0423777A3 (en) * 1989-10-19 1991-09-25 G.D. Searle & Co. Method of treating gastrointestinal motility disorders
US5432164A (en) * 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives

Also Published As

Publication number Publication date
FI941876A0 (fi) 1994-04-22
EP0609375A1 (en) 1994-08-10
WO1993008206A1 (en) 1993-04-29
NO941477D0 (no) 1994-04-22
FI941876L (fi) 1994-06-22
US5578582A (en) 1996-11-26
ZA928222B (en) 1994-04-25
AU657374B2 (en) 1995-03-09
CA2121844A1 (en) 1993-04-29
US5432164A (en) 1995-07-11
NO941477L (enExample) 1994-06-23
IL103513A0 (en) 1993-03-15
IL103513A (en) 1996-09-12
NO300461B1 (no) 1997-06-02
AU2916092A (en) 1993-05-21
JPH07500586A (ja) 1995-01-19
NZ244875A (en) 1995-04-27

Similar Documents

Publication Publication Date Title
MX9205145A (es) Nuevos derivados heterociclicos.
NL300250I2 (nl) Chinuclidinederivaten.
FI934919L (fi) Avgivningssystem med kontrollerad, foerlaengd frigivning foer roekavvaenjning
DK0680488T3 (da) 2,6-Diaminopurinderivater
FI923314L (fi) Substituerade cyklopropylamino-1,3,5-triaziner
FI924160A7 (fi) Benzanilidderivat
BR9106540A (pt) 1,4-diamino-2,3-didroxibutanos
FI941876A7 (fi) Uusia 2,6-disubstituoituja puriinijohdannaisia
FI930429A0 (fi) Nya 1,4-dihyropyridinderivat
FI923726L (fi) Sulfaterade glykosaminoglykanoidderivat
NO912804D0 (no) Purinderivater.
FI920394L (fi) 3-kinuklidinderivat.
FI925258A7 (fi) Foerfarande foer framstaellning av 2-substituerade 4,6-dialkoxipyrimidiner
DE69122555D1 (de) 2,4-Dihydroxyadipinsäurederivate
FI901277A7 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenyleeni PG1z-johdannaisia
FI925441A7 (fi) 1,4-diamino-2,3-dihydroksibutaaneja
FI931794L (fi) Monokvaternaera 2,16-bispiperidinylandrostanderivat
FI941909A0 (fi) 2,6-disubstituoidut 4-kinolyylidihydropyridiinit
FI942070L (fi) Nitroksialkyyliamidijohdannaiset
FI923542L (fi) Faestanordning foer klingor, isynnerhet i bestrykningsmaskiner
FI935657L (fi) Foerfarande foer framstaellning av 3,4-dihydroxi-5-nitrobensaldehyd
FI923201L (fi) 3,4-dehyropiperidinderivat
MX9202291A (es) Derivados carboxamido-(3,2n)-carbociclico-2-amino tetralinas.
FI921760L (fi) Viskoelastisk vattenhaltig flytande detergentkomposition, speciellt foer automatiska diskmaskiner med foerbaettrad doserbarhet
DE69219121D1 (de) Karboxamido-(1,2n)-karbocyclo-2-aminotetralinderivate

Legal Events

Date Code Title Description
FD Application lapsed